Obesity inhibits key cancer defence mechanism
Posted: 27 April 2018 | Drug Target Review | No comments yet
Obesity could enhance cancer development while aspirin might prevent it – a new insight into potential targets for cancer prevention.
‘Epithelial’ cells lining the surfaces of organs have the intrinsic ability to remove potentially malignant cells from their midst. This is called the ‘epithelial defence against cancer’ mechanism. Normally, the cells sense harmful cells and push them out by the process called cell competition.
To study how obesity affects this defence mechanism, researchers from Hokkaido University and their collaborators bred mice that were designed to express a known cancer-inducing mutant protein called Ras. Epithelial cells usually remove the potentially malignant Ras-transformed cells.
Feeding the Ras mice high-fat diets, which resulted in severe obesity, suppressed the defence mechanism and therefore increased the number of Ras-transformed cells remaining in the tissue. This suppression was seen in the intestine and pancreas, but not in the lungs. Furthermore, a month later the Ras-transformed cells developed a tumour in the pancreas of mice with the high-fat diet. The result supports previous correlations made between intestinal and pancreatic cancer and obesity, but not lung cancer.
Biomarkers are redefining how precision therapies are discovered, validated and delivered.
This exclusive expert-led report reveals how leading teams are using biomarker science to drive faster insights, cleaner data and more targeted treatments – from discovery to diagnostics.
Inside the report:
- How leading organisations are reshaping strategy with biomarker-led approaches
- Better tools for real-time decision-making – turning complex data into faster insights
- Global standardisation and assay sensitivity – what it takes to scale across networks
Discover how biomarker science is addressing the biggest hurdles in drug discovery, translational research and precision medicine – access your free copy today
Following experiments using the mice model and cultured cells revealed that fatty acids and chronic inflammation cause the suppression of the defence mechanism.
When mice fed a high-fat diet were treated with aspirin, known for its anti-inflammatory properties, the defence mechanism was substantially enhanced. This implies that reinforcing the epithelial defence mechanism with anti-inflammatory drugs could be utilised for cancer prevention.
“This is the first report to show that obesity and chronic inflammation can influence competitive interaction between normal cells and transformed cells. It implies other factors such as infection, smoking, sleeping patterns and aging may also affect cell competition,” says Yasuyuki Fujita of Hokkaido University who led the study.
